| Literature DB >> 32322185 |
Luís M Lacerda1, Jonathan D Clayden1, Sian E Handley2, Gavin P Winston3,4, Enrico Kaden5, Martin Tisdall6, J Helen Cross7, Alki Liasis2,8, Chris A Clark1.
Abstract
BACKGROUND: Surgery is a key approach for achieving seizure freedom in children with focal onset epilepsy. However, the resection can affect or be in the vicinity of the optic radiations. Multi-shell diffusion MRI and tractography can better characterize tissue structure and provide guidance to help minimize surgical related deficits. Whilst in adults tractography has been used to demonstrate that damage to the optic radiations leads to postoperative visual field deficits, this approach has yet to be properly explored in children.Entities:
Keywords: clinical; diffusion; multi-shell; pediatric; surgery; tractography; visual
Year: 2020 PMID: 32322185 PMCID: PMC7158873 DOI: 10.3389/fnins.2020.00269
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Detailed clinical information for selected patient population.
| Patient01 | 16.0 | 179 | No data | F | L temporal lesionectomy | Yes | Keppra |
| Patient02 | 7.0 | 137 | No data | M | L anterior temporal lobectomy | No | Phenytoin, sodium valproate and zonisamide |
| Patient03 | 7.0 | 236 | No data | M | L anterior temporal lobectomy and amygdalo-hippocampectomy | Yes | Sodium valproate, lamotrigine |
| Patient04 | 13.0 | 100 | 267 | F | L anterior temporal lobectomy and amygdalo-hippocampectomy | Yes | Oxcarbazepine, zonisamide |
| Patient05 | 15.0 | 167 | No data | F | L anterior temporal lobectomy and amygdalo-hippocampectomy | Yes | Carbamazepine, sodium valproate, clobazam |
| Patient06 | 6.0 | 559 | No data | F | L frontal, anterior temporal lobectomy and amygdalectomy | No | Lacosamide, phenobarbitone |
| Patient07 | 16.0 | 200 | No data | M | L posterior temporal lesionectomy | Yes | Oxcarbazepine, sodim valproate, levetiracetam |
| Patient08 | 12.0 | 168 | No data | M | L posterior temporal lesionectomy | Yes | Carbamazepine, clonazepam |
| Patient09 | 17.0 | 82 | 140 | F | L temporal lesionectomy | Yes | Tegretol |
| Patient10 | 6.0 | 117 | No data | M | L temporal lesionectomy | Yes | Levetiracetam, clobazam |
| Patient11 | 7.0 | 286 | No data | F | L anterior temporal lesionectomy and amygdalo-hippocampectomy | No | Topiramate, clobazam |
| Patient12 | 18.0 | 102 | 320 | M | L temporal lobectomy (extended) | No | Lamotrigine, lacosamide |
| Patient13 | 11.0 | 4 | 50 | M | L temporal lobectomy and amygdalo-hippocampectomy (extended) | Yes | Carbamazepine, sodium valproate, levetiracetam |
| Patient14 | 12.0 | 158 | 161 | M | L temporo-occipito-parietal disconnection | Yes | Perampanel, sodium valproate, levetiracetam |
| Patient15 | 12.0 | 89 | 98 | M | L temporo-occipito-parietal disconnection | Yes | Carbamazepine, topiramate |
| Patient16 | 11.0 | 165 | No data | M | L temporo-occipito-parietal disconnection | Yes | Carbamazepine, clobazam |
| Patient17 | 5.0 | 137 | 54 | M | R fronto-temporo-parietal resection | Yes | Levetiracetam, clobazam |
| Patient18 | 14.0 | 81 | 64 | F | R occipital lesionectomy | Yes | Sodium valproate, levetiracetam |
| Patient19 | 7.0 | 186 | No data | F | R occipital lesionectomy | No | Sodium valproate, levetiracetam |
| Patient20 | 10.0 | 308 | No data | F | R anterior temporal lobectomy and amygdalo-hippocampectomy | Yes | Sodium valproate, vigabatrin |
| Patient21 | 19.0 | 237 | No data | F | R anterior temporal lobectomy | Yes | Oxcarbazepine |
| Patient22 | 12.0 | 411 | 264 | M | R anterior temporal lobectomy and amygdalo-hippocampectomy | No | Oxcarbazepine, clobazam |
| Patient23 | 17.0 | 176 | No data | M | R anterior temporal lobectomy and amygdalo-hippocampectomy | Yes | Levetiracetam |
| Patient24 | 7.0 | 160 | No data | F | R anterior temporal lobectomy and amygdalo-hippocampectomy | No | Sodium valproate, lamotrigine, midazolam |
| Patient25 | 13.0 | 108 | 286 | M | R temporal lesionectomy | Yes | – |
| Patient26 | 10.0 | 188 | No data | F | R temporal lesionectomy | Yes | Levetiracetam |
| Patient27 | 6.0 | 287 | No data | F | L temporal lesionectomy | Yes | Sodium valproate, lamotrigine |
| Patient28 | 11.0 | 242 | No data | M | L parietal tumor resection | Yes | Zonisamide |
| Patient29 | 6.0 | 259 | No data | F | R anterior temporal lesionectomy and amygdalo-hippocampectomy | Yes | Sodium valproate, topiramate |
| Patient30 | 6.0 | 154 | No data | M | L temporal lobectomy | No | Topiramate, keppra |
| Patient31 | 5.0 | 176 | 111 | F | R temporal lesionectomy | Yes | Keppra |
| Patient32 | 9.0 | No data | 333 | M | L temporal lobectomy lesionectomy | No | Lacosamide, levetiracetam, lamotrigine, risperidone, phenytoin |
| Patient33 | 10.0 | 85 | No data | F | L parietal lesionectomy | No | Sodium valproate, levetiracetam |
| Patient34 | 6.0 | No data | No data | F | R occipital lobectomy | Yes | Keppra, lamotrigine |
| Patient35 | 13.0 | 89 | No data | F | L temporal lobectomy and amygdalo-hippocampectomy | Yes | Carbamazepine |
| Patient36 | 8.0 | No data | No data | M | R temporal lobectomy | No | Oxcarbazepine, lacosamide |
| Patient37 | 8.0 | 81 | No data | M | L parietal lesionectomy | Unavailable | Sodium valproate, oxcarbazepine |
| Patient38 | 17.0 | 73 | No data | F | R temporal lesionectomy and amygdalo-hippocampectomy | Unavailable | Keppra, oxcarbazepine, clobazam |
| Patient39 | 16.0 | 155 | 134 | M | L temporo-occipito-parietal disconnection | Unavailable | Carbamazepine, lacosamide, phenobarbitone |
| Patient40 | 18.0 | No data | No data | F | L temporal lesionectomy | Unavailable | Oxcarbazepine, midazolam |
| Patient41 | 18.0 | No data | No data | F | L parietal lesionectomy | Unavailable | Topiramate, lamotrigine, levothyroxine |
| Patient42 | 5.0 | 125 | 239 | M | R temporo-occipito-parietal disconnection | Unavailable | Carbamazepine |
| Patient43 | 15.0 | 102 | 299 | F | L temporo-occipito-parietal disconnection | Unavailable | Lacosamide, levetiracetam, lamotrigine |
FIGURE 1Structure of the data available for the current study.
FIGURE 2Calculation of the overlap score: Yellow indicates the optic radiation reconstruction, Blue the resection area and green the overlap measure, calculated as the percentage of the optic radiation disconnection, at maximum cross-sectional area. In transparent white there is a bounding box created by the limits of the optic radiation maps.
Mixed effect model results.
| MD | Intercept | 7.94E-04 | 8.04E-06 | 98.753*** | μMD | Intercept | 1.07E-03 | 8.53E-06 | 125.31*** |
| Group | 3.01E-05 | 5.01E-06 | −6.011*** | Group | 3.98E-05 | 5.40E-06 | −7.372*** | ||
| Timepoint | −5.71E-07 | 2.46E-06 | −0.232 | Timepoint | −6.29E-06 | 3.32E-06 | −1.896 | ||
| Gender | 1.48E-05 | 4.92E-06 | 2.999** | Gender | 1.62E-05 | 5.20E-06 | 3.119** | ||
| Age | −5.29E-06 | 6.12E-07 | −8.651*** | Age | −6.04E-06 | 6.47E-07 | −9.335*** | ||
| AD | Intercept | 1.23E-03 | 9.38E-06 | 130.786*** | Long | Intercept | 2.68E-03 | 1.72E-05 | 155.745*** |
| Group | 4.13E-05 | 5.93E-06 | −6.965*** | Group | 7.96E-05 | 1.09E-05 | −7.307*** | ||
| Timepoint | −3.95E-05 | 4.34E-06 | −9.109*** | Timepoint | −4.12E-05 | 7.70E-06 | −5.343*** | ||
| Gender | 2.40E-05 | 5.72E-06 | 4.187*** | Gender | 3.38E-05 | 1.05E-05 | 3.213** | ||
| Age | −4.18E-06 | 7.12E-07 | −5.868*** | Age | −9.39E-06 | 1.31E-06 | −7.182*** | ||
| RD | Intercept | 5.81E-04 | 9.56E-06 | 60.733*** | Trans | Intercept | 2.61E-04 | 7.53E-06 | 34.687*** |
| Group | 2.74E-05 | 5.97E-06 | −4.595*** | Group | 1.97E-05 | 4.68E-06 | −4.217*** | ||
| Timepoint | 1.65E-05 | 3.15E-06 | 5.227*** | Timepoint | 1.03E-05 | 2.28E-06 | 4.53*** | ||
| Gender | 1.21E-05 | 5.84E-06 | 2.067* | Gender | 9.82E-06 | 4.61E-06 | 2.132* | ||
| Age | −5.92E-06 | 7.27E-07 | −8.146*** | Age | −4.27E-06 | 5.73E-07 | −7.446*** | ||
| FA | Intercept | 4.32E-01 | 7.68E-03 | 56.281*** | μFA | Intercept | 8.86E-01 | 3.36E-03 | 263.751*** |
| Group | -8.37E-03 | 4.82E-03 | 1.737 | Group | −4.86E-03 | 2.10E-03 | 2.319* | ||
| Timepoint | −2.80E-02 | 3.16E-03 | −8.885*** | Timepoint | −6.58E-03 | 1.20E-03 | −5.494*** | ||
| Gender | −1.34E-03 | 4.69E-03 | −0.286 | Gender | −3.00E-03 | 2.05E-03 | −1.459 | ||
| Age | 3.76E-03 | 5.84E-04 | 6.439*** | Age | 1.66E-03 | 2.56E-04 | 6.506*** | ||
| OD Entropy | Intercept | 4.65E-01 | 1.12E-02 | 41.618*** | |||||
| Group | −1.07E-02 | 6.89E-03 | 1.552 | ||||||
| Timepoint | −4.37E-02 | 4.92E-03 | −8.887*** | ||||||
| Gender | 5.16E-03 | 6.85E-03 | 0.753 | ||||||
| Age | 4.50E-03 | 8.54E-04 | 5.274*** | ||||||
Summary of significant increases (↑) and decreases (↓) found as a result of the fixed effects of the fitted model, both before and after surgery.
| MD | ↑ | – |
| AD | ↑ | ↓ |
| RD | ↑ | ↑ |
| FA | – | ↓ |
| μMD | ↑ | – |
| Long | ↑ | ↓ |
| Trans | ↑ | ↑ |
| μFA | ↓ | ↓ |
| ODEntropy | – | ↓ |
FIGURE 3(A) Distribution of the resection margins for the 43 subjects in this study, per hemisphere, overlapped onto a template generated by registering all the individual structural scans. Hot color scale indicates the percentage of the total operations that were performed in a specific location. The maximum of the hot color scale indicates the highest incidence of surgical procedures for both hemispheres. (B) For a smaller subset of patients for which visual function data was available before and after surgery a small sketch of the resection locations and a table with overlap between pre-surgical tractography of the optic radiations and post-surgical structural scan are presented. R, right; L, left; HH, homonymous hemianopia; HSQ, homonymous superior quadrantanopia. *confrontational, +supported with electrophysiological data.